Global Advanced Infusion Systems

Advanced Infusion Systems Comprehensive Study by Type (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-Infectives, Endocrinology, Enteral nutrition, Chemotherapy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic centers, Bedside) Players and Region - Global Market Outlook to 2025

Advanced Infusion Systems Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Advanced Infusion Systems Market Scope
Infusion systems are medical instruments and associated disposables, used to deliver fluids or drugs in solution to a patient’s circulatory system in a controlled, precise, and automated manner. There are different routes to introduce a drug into the patient’s system, of which, the highly used mode is through intravenous, although subcutaneous, arterial, and epidural infusion are preferred as per the requirement.

The Advanced Infusion Systems market study is segmented by Type (Infusion Pump, Intravenous Sets, IV Cannulas and Needleless Connectors), by Application (Anti-Infectives, Endocrinology, Enteral nutrition and Chemotherapy) and major geographies with country level break-up.

Market players are focusing on partnerships, collaborations, and new product launches in order to increase their offerings in the insulin infusion pumps market. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Advanced Infusion Systems market throughout the predicted period.

Baxter (United States), B. Braun Melsungen AG (Germany), Care Fusion Corporation (United States), ICU Medical, Inc. (United States), Fresenius Kabi AG (Germany), JMS Co. Ltd. (Japan), Terumo Corporation (Japan), Smiths Medical (United States) and Caesarea Medical Electronics (Israel) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Advanced Infusion Systems market by Type, Application and Region.

On the basis of geography, the market of Advanced Infusion Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In October 2019, Tandem Diabetes Care and Abbott announced today that they aiming to develop and commercialize integrated diabetes solutions that combine Abbott's 1 glucose sensing technology with Tandem's advanced insulin delivery systems to deliver more efficient options for diabetic patients.



Market Trend
  • Technological Advancements in Infusion Devices
  • Increasing Malnutrition in Developing Countries

Market Drivers
  • Rising Incidences of Cancer, Diabetes, and Asthma
  • Increasing Aging Population

Opportunities
  • Emphasizing On Development of Efficient Insulin Infusion Pumps
  • Rising Demand from the Developing Economies

Restraints
  • Increased Morbidity and Mortality Rate
  • Stringent Regulatory Requirements for New Product Launch in Healthcare Market

Challenges
  • Issues Related to Reimbursement Policies


Key Target Audience
Advanced Infusion Systems Manufacturers, Government Agencies, Commercial Research & Development Institutions, Government Organizations, Research Organizations, and Consulting Firms, Trade Associations and Industry Bodies and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Infusion Pump
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
By Application
  • Anti-Infectives
  • Endocrinology
  • Enteral nutrition
  • Chemotherapy
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic centers
  • Bedside

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidences of Cancer, Diabetes, and Asthma
      • 3.2.2. Increasing Aging Population
    • 3.3. Market Challenges
      • 3.3.1. Issues Related to Reimbursement Policies
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Infusion Devices
      • 3.4.2. Increasing Malnutrition in Developing Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Advanced Infusion Systems, by Type, Application, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Advanced Infusion Systems (Value)
      • 5.2.1. Global Advanced Infusion Systems by: Type (Value)
        • 5.2.1.1. Infusion Pump
        • 5.2.1.2. Intravenous Sets
        • 5.2.1.3. IV Cannulas
        • 5.2.1.4. Needleless Connectors
      • 5.2.2. Global Advanced Infusion Systems by: Application (Value)
        • 5.2.2.1. Anti-Infectives
        • 5.2.2.2. Endocrinology
        • 5.2.2.3. Enteral nutrition
        • 5.2.2.4. Chemotherapy
      • 5.2.3. Global Advanced Infusion Systems by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Centers
        • 5.2.3.3. Diagnostic centers
        • 5.2.3.4. Bedside
      • 5.2.4. Global Advanced Infusion Systems Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Advanced Infusion Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Baxter (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. B. Braun Melsungen AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Care Fusion Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ICU Medical, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fresenius Kabi AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. JMS Co. Ltd. (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Terumo Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smiths Medical (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Caesarea Medical Electronics (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Advanced Infusion Systems Sale, by Type, Application, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Advanced Infusion Systems (Value)
      • 7.2.1. Global Advanced Infusion Systems by: Type (Value)
        • 7.2.1.1. Infusion Pump
        • 7.2.1.2. Intravenous Sets
        • 7.2.1.3. IV Cannulas
        • 7.2.1.4. Needleless Connectors
      • 7.2.2. Global Advanced Infusion Systems by: Application (Value)
        • 7.2.2.1. Anti-Infectives
        • 7.2.2.2. Endocrinology
        • 7.2.2.3. Enteral nutrition
        • 7.2.2.4. Chemotherapy
      • 7.2.3. Global Advanced Infusion Systems by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Centers
        • 7.2.3.3. Diagnostic centers
        • 7.2.3.4. Bedside
      • 7.2.4. Global Advanced Infusion Systems Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Advanced Infusion Systems: by Type(USD Million)
  • Table 2. Advanced Infusion Systems Infusion Pump , by Region USD Million (2015-2020)
  • Table 3. Advanced Infusion Systems Intravenous Sets , by Region USD Million (2015-2020)
  • Table 4. Advanced Infusion Systems IV Cannulas , by Region USD Million (2015-2020)
  • Table 5. Advanced Infusion Systems Needleless Connectors , by Region USD Million (2015-2020)
  • Table 6. Advanced Infusion Systems: by Application(USD Million)
  • Table 7. Advanced Infusion Systems Anti-Infectives , by Region USD Million (2015-2020)
  • Table 8. Advanced Infusion Systems Endocrinology , by Region USD Million (2015-2020)
  • Table 9. Advanced Infusion Systems Enteral nutrition , by Region USD Million (2015-2020)
  • Table 10. Advanced Infusion Systems Chemotherapy , by Region USD Million (2015-2020)
  • Table 11. Advanced Infusion Systems: by End User(USD Million)
  • Table 12. Advanced Infusion Systems Hospitals , by Region USD Million (2015-2020)
  • Table 13. Advanced Infusion Systems Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 14. Advanced Infusion Systems Diagnostic centers , by Region USD Million (2015-2020)
  • Table 15. Advanced Infusion Systems Bedside , by Region USD Million (2015-2020)
  • Table 16. South America Advanced Infusion Systems, by Country USD Million (2015-2020)
  • Table 17. South America Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 18. South America Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 19. South America Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 20. Brazil Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 21. Brazil Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 22. Brazil Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 23. Argentina Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 24. Argentina Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 25. Argentina Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 26. Rest of South America Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 28. Rest of South America Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 29. Asia Pacific Advanced Infusion Systems, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 31. Asia Pacific Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 32. Asia Pacific Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 33. China Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 34. China Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 35. China Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 36. Japan Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 37. Japan Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 38. Japan Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 39. India Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 40. India Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 41. India Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 42. South Korea Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 43. South Korea Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 44. South Korea Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 45. Taiwan Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 46. Taiwan Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 47. Taiwan Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 48. Australia Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 49. Australia Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 50. Australia Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 54. Europe Advanced Infusion Systems, by Country USD Million (2015-2020)
  • Table 55. Europe Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 56. Europe Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 57. Europe Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 58. Germany Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 59. Germany Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 60. Germany Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 61. France Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 62. France Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 63. France Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 64. Italy Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 65. Italy Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 66. Italy Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 67. United Kingdom Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 68. United Kingdom Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 69. United Kingdom Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 70. Netherlands Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 71. Netherlands Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 72. Netherlands Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 73. Rest of Europe Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 74. Rest of Europe Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 75. Rest of Europe Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 76. MEA Advanced Infusion Systems, by Country USD Million (2015-2020)
  • Table 77. MEA Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 78. MEA Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 79. MEA Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 80. Middle East Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 81. Middle East Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 82. Middle East Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 83. Africa Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 84. Africa Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 85. Africa Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 86. North America Advanced Infusion Systems, by Country USD Million (2015-2020)
  • Table 87. North America Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 88. North America Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 89. North America Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 90. United States Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 91. United States Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 92. United States Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 93. Canada Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 94. Canada Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 95. Canada Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 96. Mexico Advanced Infusion Systems, by Type USD Million (2015-2020)
  • Table 97. Mexico Advanced Infusion Systems, by Application USD Million (2015-2020)
  • Table 98. Mexico Advanced Infusion Systems, by End User USD Million (2015-2020)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Advanced Infusion Systems: by Type(USD Million)
  • Table 109. Advanced Infusion Systems Infusion Pump , by Region USD Million (2021-2026)
  • Table 110. Advanced Infusion Systems Intravenous Sets , by Region USD Million (2021-2026)
  • Table 111. Advanced Infusion Systems IV Cannulas , by Region USD Million (2021-2026)
  • Table 112. Advanced Infusion Systems Needleless Connectors , by Region USD Million (2021-2026)
  • Table 113. Advanced Infusion Systems: by Application(USD Million)
  • Table 114. Advanced Infusion Systems Anti-Infectives , by Region USD Million (2021-2026)
  • Table 115. Advanced Infusion Systems Endocrinology , by Region USD Million (2021-2026)
  • Table 116. Advanced Infusion Systems Enteral nutrition , by Region USD Million (2021-2026)
  • Table 117. Advanced Infusion Systems Chemotherapy , by Region USD Million (2021-2026)
  • Table 118. Advanced Infusion Systems: by End User(USD Million)
  • Table 119. Advanced Infusion Systems Hospitals , by Region USD Million (2021-2026)
  • Table 120. Advanced Infusion Systems Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 121. Advanced Infusion Systems Diagnostic centers , by Region USD Million (2021-2026)
  • Table 122. Advanced Infusion Systems Bedside , by Region USD Million (2021-2026)
  • Table 123. South America Advanced Infusion Systems, by Country USD Million (2021-2026)
  • Table 124. South America Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 125. South America Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 126. South America Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 127. Brazil Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 128. Brazil Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 129. Brazil Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 130. Argentina Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 131. Argentina Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 132. Argentina Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 133. Rest of South America Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 134. Rest of South America Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 135. Rest of South America Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 136. Asia Pacific Advanced Infusion Systems, by Country USD Million (2021-2026)
  • Table 137. Asia Pacific Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 138. Asia Pacific Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 139. Asia Pacific Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 140. China Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 141. China Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 142. China Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 143. Japan Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 144. Japan Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 145. Japan Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 146. India Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 147. India Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 148. India Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 149. South Korea Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 150. South Korea Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 151. South Korea Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 152. Taiwan Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 153. Taiwan Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 154. Taiwan Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 155. Australia Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 156. Australia Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 157. Australia Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 161. Europe Advanced Infusion Systems, by Country USD Million (2021-2026)
  • Table 162. Europe Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 163. Europe Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 164. Europe Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 165. Germany Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 166. Germany Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 167. Germany Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 168. France Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 169. France Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 170. France Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 171. Italy Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 172. Italy Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 173. Italy Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 174. United Kingdom Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 175. United Kingdom Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 176. United Kingdom Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 177. Netherlands Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 178. Netherlands Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 179. Netherlands Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 180. Rest of Europe Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 181. Rest of Europe Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 182. Rest of Europe Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 183. MEA Advanced Infusion Systems, by Country USD Million (2021-2026)
  • Table 184. MEA Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 185. MEA Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 186. MEA Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 187. Middle East Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 188. Middle East Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 189. Middle East Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 190. Africa Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 191. Africa Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 192. Africa Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 193. North America Advanced Infusion Systems, by Country USD Million (2021-2026)
  • Table 194. North America Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 195. North America Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 196. North America Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 197. United States Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 198. United States Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 199. United States Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 200. Canada Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 201. Canada Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 202. Canada Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 203. Mexico Advanced Infusion Systems, by Type USD Million (2021-2026)
  • Table 204. Mexico Advanced Infusion Systems, by Application USD Million (2021-2026)
  • Table 205. Mexico Advanced Infusion Systems, by End User USD Million (2021-2026)
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Advanced Infusion Systems: by Type USD Million (2015-2020)
  • Figure 5. Global Advanced Infusion Systems: by Application USD Million (2015-2020)
  • Figure 6. Global Advanced Infusion Systems: by End User USD Million (2015-2020)
  • Figure 7. South America Advanced Infusion Systems Share (%), by Country
  • Figure 8. Asia Pacific Advanced Infusion Systems Share (%), by Country
  • Figure 9. Europe Advanced Infusion Systems Share (%), by Country
  • Figure 10. MEA Advanced Infusion Systems Share (%), by Country
  • Figure 11. North America Advanced Infusion Systems Share (%), by Country
  • Figure 12. Global Advanced Infusion Systems share by Players 2020 (%)
  • Figure 13. Global Advanced Infusion Systems share by Players (Top 3) 2020(%)
  • Figure 14. Global Advanced Infusion Systems share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Baxter (United States) Revenue, Net Income and Gross profit
  • Figure 17. Baxter (United States) Revenue: by Geography 2020
  • Figure 18. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 19. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 20. Care Fusion Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Care Fusion Corporation (United States) Revenue: by Geography 2020
  • Figure 22. ICU Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. ICU Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Fresenius Kabi AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Fresenius Kabi AG (Germany) Revenue: by Geography 2020
  • Figure 26. JMS Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. JMS Co. Ltd. (Japan) Revenue: by Geography 2020
  • Figure 28. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Terumo Corporation (Japan) Revenue: by Geography 2020
  • Figure 30. Smiths Medical (United States) Revenue, Net Income and Gross profit
  • Figure 31. Smiths Medical (United States) Revenue: by Geography 2020
  • Figure 32. Caesarea Medical Electronics (Israel) Revenue, Net Income and Gross profit
  • Figure 33. Caesarea Medical Electronics (Israel) Revenue: by Geography 2020
  • Figure 34. Global Advanced Infusion Systems: by Type USD Million (2021-2026)
  • Figure 35. Global Advanced Infusion Systems: by Application USD Million (2021-2026)
  • Figure 36. Global Advanced Infusion Systems: by End User USD Million (2021-2026)
  • Figure 37. South America Advanced Infusion Systems Share (%), by Country
  • Figure 38. Asia Pacific Advanced Infusion Systems Share (%), by Country
  • Figure 39. Europe Advanced Infusion Systems Share (%), by Country
  • Figure 40. MEA Advanced Infusion Systems Share (%), by Country
  • Figure 41. North America Advanced Infusion Systems Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Baxter (United States)
  • B. Braun Melsungen AG (Germany)
  • Care Fusion Corporation (United States)
  • ICU Medical, Inc. (United States)
  • Fresenius Kabi AG (Germany)
  • JMS Co. Ltd. (Japan)
  • Terumo Corporation (Japan)
  • Smiths Medical (United States)
  • Caesarea Medical Electronics (Israel)
Select User Access Type

Key Highlights of Report


Dec 2020 205 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Advanced Infusion Systems Quantitative research analysis
Global Advanced Infusion Systems Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Advanced Infusion Systems Report?

Have a Query? Click Here

Other Related Reports

Fiducial Markers Comprehensive Study by Type (Polymer-Based Markers, Metal-Based Markers, Others), Application (Hospitals, Radiotherapy Centers, Cancer Research Institutes, Others), Cancer (Prostate...
$ 3650
Inhaler Devices Comprehensive Study by Type (Pressurized Metered Dose Inhaler (pMDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)), Application (Residential, Hospital, Clinic, Respiratory Care ...
$ 3800
Pregnancy Kits Comprehensive Study by Type (Digital Devices, Line Indicators, Others), Application (Hospitals, Clinics, Households, Others), Distribution Channel (Online Pharmacies, Hospital Pharmaci...
$ 3450
Extremity Products Comprehensive Study by Type (Upper Extremities, Lower Extremities), Application (Hospitals, Clinics, ASCs) Players and Region - Global Market Outlook to 2025
$ 3500
Disability Devices Comprehensive Study by Type (Vision Aids, Hearing Aids, Mobility Aids {Wheelchairs and Mobility Scooters}), Application (Hospitals, Home Care, Ambulatory Care Centers, Rehabilitati...
$ 3450
Skin Hooks Comprehensive Study by Type (Joseph Skin Hooks, Kleinert-Kutz Hook, Gillies Skin Hook, Others), Application (Abdomen Surgery, Cosmetic Surgery, Vascular Surgery, Others), Sales Channel (Di...
$ 3350